KSD-101 Therapy

· Kousai Bio Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KSD-101 Therapy, covering 2024-10-30 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial [EARLY_Phase 1]